Russia begins Dengue fever vaccine trials

Russia's Federal Medical-Biological Agency (FMBA) has begun clinical trials of a domestically developed vaccine against Dengue fever. The announcement was made by FMBA head Veronika Skvortsova. The trials represent a step in Russia's efforts to expand its public health and biotechnological capabilities. If successful, the vaccine could address a significant global health threat.